Archives
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
CB-5083: Precision Targeting of p97 to Dissect ER Protein...
2025-10-01
Explore how CB-5083, a selective p97 inhibitor, enables unparalleled investigation into the intersection of protein homeostasis disruption, ER membrane regulation, and cancer cell apoptosis. This article uniquely integrates recent mechanistic advances and offers a distinct systems biology perspective for multiple myeloma and solid tumor research.
-
Dlin-MC3-DMA: Charting New Horizons in Lipid Nanoparticle...
2025-09-30
This thought-leadership article explores the mechanistic and strategic dimensions of Dlin-MC3-DMA as a transformative ionizable cationic lipid for lipid nanoparticle (LNP) siRNA and mRNA delivery. Integrating molecular insights, recent machine learning advances, and translational priorities, it provides guidance for researchers seeking to optimize gene silencing, vaccine platforms, and next-generation cancer immunochemotherapy.
-
X-press Tag Peptide: Precision Tools for Post-Translation...
2025-09-29
Discover how the X-press Tag Peptide enables advanced protein purification and precise detection in post-translational modification research, including mTORC1 signaling. This in-depth guide reveals unique technical insights and applications not covered elsewhere.
-
HotStart™ 2X Green qPCR Master Mix: Precision Tools for R...
2025-09-28
Explore how HotStart™ 2X Green qPCR Master Mix advances RNA-targeted drug discovery by enabling high-specificity gene expression analysis and nucleic acid quantification. This article reveals unique workflows integrating cgSHAPE-seq, offering insights beyond standard SYBR Green qPCR protocols.
-
ISRIB (trans-isomer): Pioneering Integrated Stress Respon...
2025-09-27
Discover how ISRIB (trans-isomer), a potent integrated stress response inhibitor, enables advanced mechanistic and translational research from cellular stress to complex disease models. This article offers a unique, in-depth perspective on ISRIB’s role in eIF2α phosphorylation inhibition, apoptosis assays, and cognitive enhancement.
-
Dlin-MC3-DMA: Optimizing Lipid Nanoparticle Systems for P...
2025-09-26
Explore how Dlin-MC3-DMA, a leading ionizable cationic liposome, drives next-generation lipid nanoparticle siRNA delivery and mRNA drug delivery lipid systems. This article reveals unique insights into predictive optimization, molecular mechanisms, and translational strategies for gene silencing and mRNA vaccine formulation.
-
Nitrocefin in Precision β-Lactamase Phenotyping: From Mec...
2025-09-25
Explore how Nitrocefin, a premier chromogenic cephalosporin substrate, empowers precision β-lactamase detection substrate assays for advanced antibiotic resistance profiling. Discover unique insights into benchmarking microbial resistance mechanisms and optimizing inhibitor screening workflows.
-
FLAG tag Peptide (DYKDDDDK): Enabling Precision in Kinesi...
2025-09-24
Explore how the FLAG tag Peptide (DYKDDDDK) empowers advanced recombinant protein purification and functional motor protein research. This article uniquely examines its role in dissecting molecular mechanisms, including recent breakthroughs in adaptor-mediated kinesin activation.
-
ISRIB (trans-isomer): Mechanistic Insights for Targeting ...
2025-09-23
Explore how ISRIB (trans-isomer), a potent integrated stress response inhibitor, is reshaping ER stress research by targeting ATF4 and eIF2B activation. This article analyzes mechanistic advances and translational relevance in disease models, with a focus on liver fibrosis and neurodegeneration.
-
br Development of lorlatinib from crizotinib to a clinical
2025-03-03
Development of lorlatinib from crizotinib (1) to a clinical candidate (6) Xalkori (1, PF-02341066, crizotinib), was the first-in-class ALK inhibitor approved by the Unites States Food and Drug Administration (FDA) in 2011 as a first-line treatment for ALK+- NSCLC patients. This section describes
-
br Special report Financial and personal
2025-03-03
Special report – Financial and personal benefits of early diagnosis Acknowledgments The Alzheimer’s Association acknowledges the contributions of Joseph Gaugler, Ph.D., Bryan James, Ph.D., Tricia Johnson, Ph.D., Allison Marin, Ph.D., and Jennifer Weuve, M.P.H., Sc.D., in the preparation of 201
-
EIPA Active SI behavior was dose dependently
2025-03-03
Active SI behavior was dose-dependently affected by PACAP treatment (F3,25 = 14.42, p affected EIPA 1 week later (F3,20 = 8.93, p results are consistent with our hypothesis that PACAP causes disruptions in posterror adjustments that are similar to disruptions seen in humans with depression.
-
ACE inhibition is often thought to play
2025-03-03
ACE inhibition is often thought to play a central role in the mechanisms of blood pressure reduction in vivo, and most ACE inhibitory (ACEi) peptides were characterized based on in vitro ACE inhibition. A relationship between in vitro ACE inhibition and antihypertensive activity, however, is not app
-
MRT68921 To help ensure the fidelity of
2025-03-03
To help ensure the fidelity of mitosis and cytokinesis cells monitor these processes and delay cell cycle progression in response to certain defects. The spindle assembly checkpoint (SAC) is a surveillance system which delays MRT68921 onset until a bipolar spindle has been correctly assembled (Lara
-
In Rainey et al published
2025-03-01
In 2008, Rainey et al. published the results of a targeted compound library screen for potential inhibitors of the ATM kinase. In this study, the compound CP466722 was identified as a highly selective and rapidly reversible ATM inhibitor, which did not inhibit PI3K or related PIKK family members. Mo